The results from the Western blot analysis indicate that normal bronchial epithelial cells and lung cancer cells may have different splice variants of ACSL1; however, it is not yet clear whether or to which extent this discrepancy may cause any biological impact on tumor cells. This evidence concerns the gene ACSL1 and lung carcinoma.